Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paula M. Fracasso, MD, PhD
Washington University Siteman Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
Orange, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- New Britain General Hospital
New Britain, Connecticut, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Long Island Cancer Center at Stony Brook University Hospital
Stony Brook, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Mount Carmel West Hospital
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
- Southeast Gynecologic Oncology Associates
Knoxville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
Nashville, Tennessee, United States
- Ccop - Scott and White Hospital
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 1999
- Primary completion
- —
- Completion
- 30 Sept 2007
- Last update posted
- 24 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00071929
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.